Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Troponin I | 21 | 2021 | 656 | 3.440 |
Why?
|
Troponin | 10 | 2021 | 532 | 2.210 |
Why?
|
Acute Coronary Syndrome | 25 | 2023 | 2185 | 1.770 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 16 | 2004 | 150 | 1.740 |
Why?
|
Natriuretic Peptide, Brain | 27 | 2024 | 1735 | 1.740 |
Why?
|
Heart Failure, Systolic | 3 | 2020 | 135 | 1.640 |
Why?
|
Potassium | 3 | 2022 | 1312 | 1.510 |
Why?
|
Troponin T | 12 | 2024 | 785 | 1.470 |
Why?
|
Heart Failure | 43 | 2024 | 11837 | 1.400 |
Why?
|
Phlebotomy | 2 | 2022 | 138 | 1.170 |
Why?
|
Blood Chemical Analysis | 3 | 2018 | 434 | 1.100 |
Why?
|
Growth Differentiation Factor 15 | 6 | 2024 | 198 | 1.030 |
Why?
|
Limit of Detection | 9 | 2021 | 271 | 1.000 |
Why?
|
Immunoassay | 8 | 2021 | 742 | 0.910 |
Why?
|
Tandem Mass Spectrometry | 8 | 2020 | 1194 | 0.880 |
Why?
|
Spherocytosis, Hereditary | 9 | 2003 | 83 | 0.850 |
Why?
|
Peptide Fragments | 20 | 2024 | 5126 | 0.770 |
Why?
|
Hemolysis | 2 | 2022 | 407 | 0.750 |
Why?
|
Drug Monitoring | 5 | 2021 | 960 | 0.680 |
Why?
|
Clinical Chemistry Tests | 3 | 2015 | 59 | 0.610 |
Why?
|
Exercise Test | 7 | 2020 | 2185 | 0.610 |
Why?
|
Fibroblast Growth Factors | 4 | 2019 | 871 | 0.610 |
Why?
|
Blood Group Antigens | 4 | 2004 | 183 | 0.590 |
Why?
|
Heart Injuries | 2 | 2018 | 207 | 0.580 |
Why?
|
Atrial Fibrillation | 10 | 2024 | 5186 | 0.570 |
Why?
|
Chemistry, Clinical | 2 | 2007 | 64 | 0.560 |
Why?
|
Myocardial Infarction | 19 | 2023 | 11508 | 0.550 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2017 | 171 | 0.540 |
Why?
|
Laboratories | 4 | 2022 | 463 | 0.540 |
Why?
|
Erythrocyte Membrane | 12 | 2003 | 428 | 0.530 |
Why?
|
Spectrin | 10 | 1997 | 174 | 0.530 |
Why?
|
Troponin C | 1 | 2016 | 48 | 0.520 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 5 | 2019 | 1513 | 0.510 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 2020 | 1527 | 0.510 |
Why?
|
Atherosclerosis | 10 | 2023 | 3419 | 0.500 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.500 |
Why?
|
Kidney Failure, Chronic | 6 | 2019 | 2504 | 0.490 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2023 | 12235 | 0.480 |
Why?
|
Chromatography, Liquid | 4 | 2014 | 991 | 0.450 |
Why?
|
Stroke Volume | 18 | 2023 | 5595 | 0.440 |
Why?
|
Urinalysis | 2 | 2013 | 369 | 0.430 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 192 | 0.430 |
Why?
|
Embolism | 3 | 2023 | 401 | 0.430 |
Why?
|
Utilization Review | 1 | 2015 | 381 | 0.430 |
Why?
|
Refrigeration | 1 | 2013 | 27 | 0.430 |
Why?
|
Tumor Lysis Syndrome | 1 | 2013 | 38 | 0.430 |
Why?
|
Urate Oxidase | 1 | 2013 | 33 | 0.420 |
Why?
|
Cardiomyopathy, Hypertrophic | 5 | 2024 | 1338 | 0.410 |
Why?
|
Humans | 186 | 2024 | 765926 | 0.410 |
Why?
|
Cost Control | 1 | 2015 | 625 | 0.410 |
Why?
|
Immunoenzyme Techniques | 3 | 2012 | 1695 | 0.400 |
Why?
|
Elliptocytosis, Hereditary | 6 | 1995 | 29 | 0.400 |
Why?
|
Performance-Enhancing Substances | 1 | 2012 | 31 | 0.390 |
Why?
|
Doping in Sports | 1 | 2012 | 63 | 0.390 |
Why?
|
Antifungal Agents | 1 | 2017 | 769 | 0.390 |
Why?
|
Calgranulin A | 3 | 2021 | 80 | 0.390 |
Why?
|
Uracil | 3 | 2018 | 210 | 0.380 |
Why?
|
Calgranulin B | 3 | 2021 | 87 | 0.380 |
Why?
|
Ankyrins | 6 | 2003 | 123 | 0.370 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2023 | 2136 | 0.370 |
Why?
|
Prognosis | 33 | 2024 | 29890 | 0.370 |
Why?
|
Founder Effect | 3 | 2020 | 185 | 0.360 |
Why?
|
Atrial Natriuretic Factor | 5 | 2019 | 347 | 0.360 |
Why?
|
Myocardium | 3 | 2015 | 4764 | 0.350 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2010 | 110 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2018 | 2307 | 0.340 |
Why?
|
Middle Aged | 81 | 2024 | 223016 | 0.340 |
Why?
|
Cardiovascular Diseases | 13 | 2023 | 15645 | 0.330 |
Why?
|
Glucosides | 3 | 2024 | 532 | 0.330 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 246 | 0.330 |
Why?
|
Anabolic Agents | 1 | 2012 | 256 | 0.330 |
Why?
|
Chest Pain | 5 | 2019 | 1102 | 0.330 |
Why?
|
Male | 109 | 2024 | 363815 | 0.320 |
Why?
|
Heart Transplantation | 2 | 2021 | 3310 | 0.310 |
Why?
|
Thiazoles | 4 | 2021 | 1528 | 0.310 |
Why?
|
Mutation | 19 | 2020 | 30192 | 0.300 |
Why?
|
Sarcomeres | 3 | 2024 | 379 | 0.300 |
Why?
|
Kidney Transplantation | 4 | 2018 | 4277 | 0.300 |
Why?
|
Female | 110 | 2024 | 396141 | 0.290 |
Why?
|
Heart-Assist Devices | 1 | 2018 | 1297 | 0.290 |
Why?
|
Cost Savings | 1 | 2013 | 900 | 0.290 |
Why?
|
Autoanalysis | 1 | 2007 | 70 | 0.290 |
Why?
|
Tachycardia, Ventricular | 2 | 2016 | 1313 | 0.280 |
Why?
|
Sensitivity and Specificity | 15 | 2021 | 14643 | 0.280 |
Why?
|
Uric Acid | 1 | 2013 | 809 | 0.270 |
Why?
|
Proteomics | 4 | 2024 | 3906 | 0.270 |
Why?
|
Acetanilides | 3 | 2014 | 167 | 0.270 |
Why?
|
Aged | 62 | 2024 | 171163 | 0.270 |
Why?
|
Aortic Diseases | 3 | 2018 | 741 | 0.260 |
Why?
|
Reticulocytes | 7 | 1998 | 287 | 0.260 |
Why?
|
Hemorrhage | 5 | 2023 | 3466 | 0.260 |
Why?
|
Blood Glucose | 4 | 2017 | 6422 | 0.260 |
Why?
|
Antibodies, Viral | 5 | 2024 | 3213 | 0.250 |
Why?
|
Glucuronidase | 2 | 2019 | 205 | 0.240 |
Why?
|
Erythrocytes | 9 | 2003 | 2394 | 0.240 |
Why?
|
Ventricular Function, Left | 8 | 2023 | 3930 | 0.240 |
Why?
|
Piperidines | 4 | 2018 | 1664 | 0.240 |
Why?
|
HIV Seropositivity | 1 | 2010 | 961 | 0.240 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2232 | 0.240 |
Why?
|
Biological Assay | 3 | 2017 | 626 | 0.230 |
Why?
|
AIDS Vaccines | 1 | 2010 | 898 | 0.230 |
Why?
|
Risk Assessment | 18 | 2024 | 24275 | 0.220 |
Why?
|
Medication Adherence | 2 | 2013 | 2190 | 0.220 |
Why?
|
Adamantane | 2 | 2015 | 148 | 0.220 |
Why?
|
Multiple Myeloma | 3 | 2021 | 5189 | 0.220 |
Why?
|
Point Mutation | 4 | 1997 | 1590 | 0.220 |
Why?
|
Benzhydryl Compounds | 4 | 2024 | 943 | 0.220 |
Why?
|
Pyridines | 4 | 2021 | 2885 | 0.220 |
Why?
|
HIV Antibodies | 1 | 2010 | 1337 | 0.220 |
Why?
|
Nijmegen Breakage Syndrome | 2 | 2016 | 4 | 0.220 |
Why?
|
Ventricular Remodeling | 3 | 2024 | 1276 | 0.210 |
Why?
|
Antibodies, Monoclonal | 3 | 2017 | 9239 | 0.210 |
Why?
|
Anticholesteremic Agents | 2 | 2021 | 970 | 0.210 |
Why?
|
Stroke | 7 | 2023 | 9739 | 0.210 |
Why?
|
Dipeptides | 2 | 2015 | 386 | 0.210 |
Why?
|
P-Selectin | 2 | 2021 | 598 | 0.210 |
Why?
|
Acidosis, Renal Tubular | 2 | 2004 | 50 | 0.200 |
Why?
|
Catheter Ablation | 1 | 2016 | 2787 | 0.200 |
Why?
|
Adiponectin | 2 | 2019 | 1120 | 0.200 |
Why?
|
Kidney Function Tests | 3 | 2017 | 684 | 0.200 |
Why?
|
Obstetric Labor, Premature | 1 | 2004 | 268 | 0.200 |
Why?
|
Exercise Tolerance | 4 | 2020 | 841 | 0.190 |
Why?
|
Clinical Laboratory Techniques | 1 | 2007 | 746 | 0.190 |
Why?
|
Alleles | 8 | 2019 | 6891 | 0.190 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2020 | 3249 | 0.190 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15401 | 0.190 |
Why?
|
Endothelium, Vascular | 3 | 2015 | 4423 | 0.190 |
Why?
|
Testosterone | 1 | 2012 | 2495 | 0.180 |
Why?
|
Coronary Disease | 4 | 2011 | 5919 | 0.180 |
Why?
|
Hematologic Tests | 1 | 2022 | 239 | 0.180 |
Why?
|
Insulin | 2 | 2014 | 6603 | 0.180 |
Why?
|
Erythrocytes, Abnormal | 3 | 2002 | 122 | 0.180 |
Why?
|
Genes, Dominant | 4 | 2004 | 855 | 0.180 |
Why?
|
Glomerular Filtration Rate | 5 | 2018 | 2233 | 0.180 |
Why?
|
Antigens, Surface | 2 | 2011 | 1616 | 0.180 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 38 | 0.180 |
Why?
|
Buprenorphine | 3 | 2014 | 665 | 0.180 |
Why?
|
Blood Proteins | 4 | 2016 | 1186 | 0.180 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2016 | 506 | 0.180 |
Why?
|
Receptors, LDL | 4 | 2016 | 492 | 0.180 |
Why?
|
Heart Diseases | 1 | 2014 | 2818 | 0.180 |
Why?
|
Cholesterol | 2 | 2020 | 2902 | 0.180 |
Why?
|
Double-Blind Method | 11 | 2019 | 12417 | 0.180 |
Why?
|
Glycopeptides | 4 | 2016 | 225 | 0.180 |
Why?
|
Lymphocyte Activation | 7 | 2019 | 5500 | 0.170 |
Why?
|
Fibronectins | 1 | 2004 | 720 | 0.170 |
Why?
|
Hospitalization | 10 | 2021 | 10810 | 0.170 |
Why?
|
Arginine | 2 | 1995 | 931 | 0.170 |
Why?
|
Antiporters | 2 | 1998 | 275 | 0.170 |
Why?
|
Metformin | 4 | 2022 | 904 | 0.160 |
Why?
|
Antibodies | 2 | 2019 | 2415 | 0.160 |
Why?
|
Immunoglobulin M | 2 | 2021 | 1527 | 0.160 |
Why?
|
Reproducibility of Results | 8 | 2021 | 20133 | 0.160 |
Why?
|
Peptide Library | 1 | 2001 | 351 | 0.160 |
Why?
|
Chronic Disease | 7 | 2020 | 9351 | 0.160 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 618 | 0.160 |
Why?
|
Molecular Sequence Data | 13 | 2006 | 17596 | 0.160 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 32 | 0.160 |
Why?
|
Heterozygote | 5 | 2020 | 2796 | 0.160 |
Why?
|
Systole | 2 | 2018 | 935 | 0.160 |
Why?
|
Sodium | 3 | 2020 | 1591 | 0.160 |
Why?
|
Spironolactone | 2 | 2020 | 415 | 0.160 |
Why?
|
Interleukin-1 | 1 | 2003 | 1242 | 0.160 |
Why?
|
Polymerase Chain Reaction | 11 | 2003 | 6058 | 0.160 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2021 | 305 | 0.160 |
Why?
|
Natriuretic Peptides | 1 | 2020 | 153 | 0.160 |
Why?
|
Shock, Cardiogenic | 1 | 2024 | 705 | 0.160 |
Why?
|
DNA, Complementary | 7 | 2003 | 1984 | 0.150 |
Why?
|
Membrane Proteins | 6 | 2021 | 7847 | 0.150 |
Why?
|
Polymorphism, Single-Stranded Conformational | 5 | 2003 | 325 | 0.150 |
Why?
|
Mannitol | 1 | 2019 | 176 | 0.150 |
Why?
|
C-Reactive Protein | 7 | 2019 | 3851 | 0.150 |
Why?
|
Fentanyl | 2 | 2013 | 451 | 0.150 |
Why?
|
Risk Factors | 25 | 2023 | 74850 | 0.150 |
Why?
|
Patient Compliance | 1 | 2009 | 2693 | 0.150 |
Why?
|
Exercise | 5 | 2020 | 5936 | 0.150 |
Why?
|
Coronary Restenosis | 1 | 2021 | 396 | 0.150 |
Why?
|
Amino Acid Substitution | 2 | 2019 | 1740 | 0.150 |
Why?
|
Vitamin D | 1 | 2012 | 3272 | 0.150 |
Why?
|
Cloning, Molecular | 3 | 2001 | 4163 | 0.150 |
Why?
|
Isoantigens | 2 | 1997 | 561 | 0.150 |
Why?
|
Symporters | 1 | 2020 | 362 | 0.150 |
Why?
|
Immunoglobulins, Thyroid-Stimulating | 1 | 2017 | 34 | 0.150 |
Why?
|
Analgesics, Opioid | 3 | 2014 | 3834 | 0.140 |
Why?
|
Immunoelectrophoresis | 1 | 2017 | 94 | 0.140 |
Why?
|
Plaque, Atherosclerotic | 4 | 2018 | 1529 | 0.140 |
Why?
|
Substance Abuse Detection | 2 | 2012 | 301 | 0.140 |
Why?
|
RNA, Messenger | 9 | 2004 | 12768 | 0.140 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 645 | 0.140 |
Why?
|
Collagen Type I | 2 | 2019 | 616 | 0.140 |
Why?
|
Luminescent Measurements | 2 | 2010 | 340 | 0.140 |
Why?
|
Piperazines | 3 | 2014 | 2546 | 0.140 |
Why?
|
Adult | 37 | 2024 | 223088 | 0.140 |
Why?
|
Thyroglobulin | 1 | 2017 | 111 | 0.140 |
Why?
|
Coronary Artery Bypass | 3 | 2014 | 2188 | 0.140 |
Why?
|
Itraconazole | 1 | 2017 | 43 | 0.140 |
Why?
|
Electrocardiography | 5 | 2017 | 6409 | 0.140 |
Why?
|
Secondary Prevention | 2 | 2021 | 1470 | 0.140 |
Why?
|
Base Sequence | 12 | 1996 | 12405 | 0.140 |
Why?
|
Diuretics | 1 | 2020 | 611 | 0.140 |
Why?
|
Receptors, Interleukin | 1 | 2018 | 243 | 0.140 |
Why?
|
Graft Rejection | 3 | 2021 | 4503 | 0.140 |
Why?
|
Reference Values | 5 | 2017 | 4909 | 0.130 |
Why?
|
Fluconazole | 1 | 2017 | 154 | 0.130 |
Why?
|
Patient Admission | 1 | 2004 | 1365 | 0.130 |
Why?
|
Proportional Hazards Models | 7 | 2021 | 12529 | 0.130 |
Why?
|
Glycoproteins | 1 | 2004 | 2196 | 0.130 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 2 | 2016 | 59 | 0.130 |
Why?
|
Substance-Related Disorders | 2 | 2012 | 4418 | 0.130 |
Why?
|
Insulin Resistance | 3 | 2022 | 3988 | 0.130 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2017 | 85 | 0.130 |
Why?
|
Receptors, Interleukin-18 | 1 | 2015 | 25 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2017 | 317 | 0.120 |
Why?
|
Genetic Variation | 1 | 2010 | 6612 | 0.120 |
Why?
|
DNA, Satellite | 1 | 1995 | 67 | 0.120 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.120 |
Why?
|
Myocardial Ischemia | 4 | 2019 | 2132 | 0.120 |
Why?
|
Treatment Outcome | 14 | 2023 | 65194 | 0.120 |
Why?
|
Survival Analysis | 5 | 2018 | 10086 | 0.120 |
Why?
|
Thromboembolism | 1 | 2021 | 1001 | 0.120 |
Why?
|
Prospective Studies | 20 | 2021 | 54807 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6503 | 0.120 |
Why?
|
Minisatellite Repeats | 1 | 1995 | 162 | 0.120 |
Why?
|
Endothelin-1 | 4 | 2023 | 295 | 0.120 |
Why?
|
Cell Cycle Proteins | 3 | 2016 | 3431 | 0.110 |
Why?
|
Renin-Angiotensin System | 1 | 2019 | 736 | 0.110 |
Why?
|
Heart Rate | 3 | 2016 | 4203 | 0.110 |
Why?
|
Galectin 3 | 2 | 2016 | 238 | 0.110 |
Why?
|
Time Factors | 10 | 2019 | 40097 | 0.110 |
Why?
|
Anticoagulants | 4 | 2024 | 4856 | 0.110 |
Why?
|
Protein Array Analysis | 1 | 2015 | 398 | 0.110 |
Why?
|
Amino Acid Sequence | 7 | 2006 | 13398 | 0.110 |
Why?
|
Pain | 1 | 2009 | 5077 | 0.110 |
Why?
|
Interleukin-18 | 1 | 2015 | 251 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2024 | 22228 | 0.110 |
Why?
|
Central Nervous System Diseases | 1 | 2018 | 519 | 0.110 |
Why?
|
Morphine Derivatives | 1 | 2013 | 43 | 0.110 |
Why?
|
Methotrexate | 1 | 2020 | 1719 | 0.110 |
Why?
|
Antihypertensive Agents | 2 | 2020 | 2028 | 0.110 |
Why?
|
Shear Strength | 1 | 2013 | 160 | 0.100 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 805 | 0.100 |
Why?
|
Hypotension | 1 | 2019 | 885 | 0.100 |
Why?
|
HIV-1 | 1 | 2010 | 6945 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4342 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2021 | 10380 | 0.100 |
Why?
|
Chemokine CCL2 | 2 | 2007 | 602 | 0.100 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.100 |
Why?
|
Lymphocytes | 2 | 2023 | 2601 | 0.100 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3716 | 0.100 |
Why?
|
Chromosome Deletion | 2 | 2021 | 1384 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4555 | 0.100 |
Why?
|
Tramadol | 1 | 2013 | 63 | 0.100 |
Why?
|
Standard of Care | 1 | 2017 | 568 | 0.100 |
Why?
|
E-Selectin | 2 | 2006 | 576 | 0.100 |
Why?
|
Thrombosis | 2 | 2021 | 2955 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5752 | 0.100 |
Why?
|
Indoles | 3 | 2019 | 1833 | 0.100 |
Why?
|
Reproduction | 1 | 2016 | 645 | 0.100 |
Why?
|
Registries | 4 | 2024 | 8346 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 1060 | 0.100 |
Why?
|
Confidence Intervals | 1 | 2017 | 2915 | 0.100 |
Why?
|
Interleukin-6 | 2 | 2017 | 3225 | 0.100 |
Why?
|
Anemia | 2 | 2011 | 1514 | 0.100 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2013 | 291 | 0.100 |
Why?
|
Triazoles | 1 | 2017 | 898 | 0.090 |
Why?
|
Pedigree | 8 | 2020 | 4535 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2015 | 899 | 0.090 |
Why?
|
Th17 Cells | 1 | 2018 | 786 | 0.090 |
Why?
|
Anemia, Hemolytic | 1 | 1992 | 164 | 0.090 |
Why?
|
Methemoglobin | 1 | 1990 | 25 | 0.090 |
Why?
|
Nuclear Proteins | 3 | 2016 | 5782 | 0.090 |
Why?
|
Haplotypes | 3 | 2016 | 2726 | 0.090 |
Why?
|
Cohort Studies | 11 | 2019 | 41680 | 0.090 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39228 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1433 | 0.090 |
Why?
|
Vasodilation | 1 | 2015 | 969 | 0.090 |
Why?
|
Hemeproteins | 1 | 1990 | 61 | 0.090 |
Why?
|
Peptides | 3 | 2019 | 4331 | 0.090 |
Why?
|
Proline | 1 | 1992 | 452 | 0.090 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2014 | 1898 | 0.090 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 393 | 0.090 |
Why?
|
Kidney Diseases | 2 | 2011 | 2100 | 0.090 |
Why?
|
Salvage Therapy | 1 | 2017 | 1272 | 0.090 |
Why?
|
Polymorphism, Genetic | 6 | 2007 | 4249 | 0.090 |
Why?
|
CD40 Ligand | 2 | 2021 | 528 | 0.090 |
Why?
|
Guideline Adherence | 1 | 2020 | 2234 | 0.090 |
Why?
|
Decision Making | 1 | 2004 | 3955 | 0.080 |
Why?
|
Myeloablative Agonists | 1 | 2010 | 215 | 0.080 |
Why?
|
Narcotics | 1 | 2012 | 333 | 0.080 |
Why?
|
Procollagen | 1 | 2010 | 189 | 0.080 |
Why?
|
Thrombolytic Therapy | 2 | 2021 | 2050 | 0.080 |
Why?
|
Frameshift Mutation | 3 | 2003 | 392 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2838 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 3111 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4782 | 0.080 |
Why?
|
Sex Factors | 3 | 2018 | 10611 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9525 | 0.080 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13446 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2019 | 1791 | 0.080 |
Why?
|
Serine Endopeptidases | 1 | 2014 | 1024 | 0.080 |
Why?
|
Absorptiometry, Photon | 1 | 2015 | 1707 | 0.080 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1148 | 0.080 |
Why?
|
Dendritic Cells | 2 | 2019 | 2745 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2016 | 2411 | 0.080 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7871 | 0.080 |
Why?
|
Mortality | 2 | 2017 | 2910 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1886 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12059 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2015 | 1894 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1604 | 0.080 |
Why?
|
Myocarditis | 2 | 2006 | 803 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2020 | 4909 | 0.080 |
Why?
|
Echocardiography | 5 | 2021 | 5040 | 0.080 |
Why?
|
Cytoskeletal Proteins | 2 | 1992 | 1322 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2019 | 10256 | 0.080 |
Why?
|
Hemoglobins | 2 | 1994 | 1531 | 0.080 |
Why?
|
Specimen Handling | 1 | 2013 | 704 | 0.080 |
Why?
|
Chromosome Disorders | 2 | 2021 | 498 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2010 | 956 | 0.070 |
Why?
|
Benzaldehydes | 2 | 2018 | 59 | 0.070 |
Why?
|
Nanoparticles | 1 | 2019 | 1966 | 0.070 |
Why?
|
Disease Progression | 5 | 2019 | 13614 | 0.070 |
Why?
|
Mice, Knockout | 7 | 2019 | 14450 | 0.070 |
Why?
|
Disease Models, Animal | 8 | 2019 | 18292 | 0.070 |
Why?
|
Phenotype | 9 | 2020 | 16714 | 0.070 |
Why?
|
Up-Regulation | 1 | 2017 | 4130 | 0.070 |
Why?
|
Blotting, Western | 2 | 2010 | 5019 | 0.070 |
Why?
|
Introns | 3 | 1996 | 965 | 0.070 |
Why?
|
Gene Expression | 4 | 2019 | 7581 | 0.070 |
Why?
|
Ventricular Dysfunction | 1 | 2008 | 143 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2021 | 59496 | 0.070 |
Why?
|
Risk | 6 | 2019 | 9599 | 0.070 |
Why?
|
Codon | 3 | 1995 | 599 | 0.070 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 22327 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8037 | 0.070 |
Why?
|
Plasma Cells | 2 | 2021 | 596 | 0.070 |
Why?
|
Urotensins | 1 | 2006 | 7 | 0.070 |
Why?
|
Cell Migration Inhibition | 1 | 2006 | 97 | 0.070 |
Why?
|
Sulfates | 2 | 1998 | 375 | 0.070 |
Why?
|
Mannose-Binding Lectin | 1 | 2007 | 146 | 0.070 |
Why?
|
Cytoskeleton | 2 | 1990 | 1178 | 0.070 |
Why?
|
Oximes | 2 | 2018 | 305 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2016 | 10426 | 0.070 |
Why?
|
Blood Component Removal | 1 | 2007 | 124 | 0.070 |
Why?
|
Recovery of Function | 1 | 2016 | 2963 | 0.070 |
Why?
|
Antibody Formation | 2 | 2021 | 1392 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1411 | 0.060 |
Why?
|
Endothelins | 1 | 2006 | 127 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2020 | 18074 | 0.060 |
Why?
|
Mice | 13 | 2021 | 81782 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2311 | 0.060 |
Why?
|
Macrophages | 3 | 2016 | 5772 | 0.060 |
Why?
|
Immunity, Innate | 2 | 2015 | 3078 | 0.060 |
Why?
|
Receptors, Chemokine | 2 | 2006 | 651 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1961 | 0.060 |
Why?
|
Blood Gas Analysis | 1 | 2007 | 382 | 0.060 |
Why?
|
Pravastatin | 3 | 2016 | 391 | 0.060 |
Why?
|
Animals | 20 | 2021 | 168735 | 0.060 |
Why?
|
Hemodynamics | 3 | 2021 | 4186 | 0.060 |
Why?
|
Coculture Techniques | 2 | 2016 | 1336 | 0.060 |
Why?
|
Glucose | 2 | 2020 | 4335 | 0.060 |
Why?
|
Protein Precursors | 3 | 2016 | 1133 | 0.060 |
Why?
|
Postoperative Complications | 4 | 2017 | 15802 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2011 | 1150 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4405 | 0.060 |
Why?
|
Exons | 4 | 1996 | 2393 | 0.060 |
Why?
|
Warfarin | 2 | 2023 | 1494 | 0.060 |
Why?
|
Flow Cytometry | 3 | 2019 | 5880 | 0.060 |
Why?
|
Artifacts | 1 | 2014 | 1896 | 0.060 |
Why?
|
Cardiomyopathies | 1 | 2018 | 2068 | 0.060 |
Why?
|
Receptors, Cell Surface | 2 | 2007 | 2814 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 192 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2012 | 1457 | 0.060 |
Why?
|
Acute Disease | 4 | 2014 | 7236 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8522 | 0.060 |
Why?
|
Chemokine CCL5 | 2 | 2003 | 213 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3788 | 0.060 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2021 | 277 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2022 | 26380 | 0.060 |
Why?
|
Heart Ventricles | 1 | 2017 | 3833 | 0.060 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2006 | 239 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2011 | 968 | 0.060 |
Why?
|
Cell Movement | 2 | 2006 | 5190 | 0.060 |
Why?
|
RNA | 4 | 1997 | 2716 | 0.060 |
Why?
|
Blood Pressure | 2 | 2018 | 8530 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
Adrenomedullin | 2 | 2016 | 85 | 0.060 |
Why?
|
Cells, Cultured | 6 | 2016 | 18962 | 0.060 |
Why?
|
T-Box Domain Proteins | 1 | 2006 | 469 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2017 | 2354 | 0.060 |
Why?
|
Coronary Artery Disease | 3 | 2018 | 6544 | 0.060 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2011 | 1800 | 0.050 |
Why?
|
DNA | 5 | 1997 | 7193 | 0.050 |
Why?
|
Transplantation Conditioning | 1 | 2010 | 1635 | 0.050 |
Why?
|
Conserved Sequence | 2 | 1998 | 1159 | 0.050 |
Why?
|
RNA Processing, Post-Transcriptional | 2 | 1997 | 392 | 0.050 |
Why?
|
Asia, Southeastern | 3 | 1994 | 115 | 0.050 |
Why?
|
Slovakia | 2 | 2016 | 9 | 0.050 |
Why?
|
Chemokine CXCL6 | 1 | 2003 | 14 | 0.050 |
Why?
|
DNA Mutational Analysis | 4 | 2007 | 4111 | 0.050 |
Why?
|
Czech Republic | 2 | 2016 | 75 | 0.050 |
Why?
|
DNA Primers | 4 | 1995 | 2824 | 0.050 |
Why?
|
Dominican Republic | 1 | 2023 | 78 | 0.050 |
Why?
|
Amitriptyline | 1 | 2003 | 110 | 0.050 |
Why?
|
Chromans | 1 | 2003 | 116 | 0.050 |
Why?
|
Drug Prescriptions | 2 | 2011 | 1662 | 0.050 |
Why?
|
International Normalized Ratio | 1 | 2005 | 382 | 0.050 |
Why?
|
Pilot Projects | 5 | 2019 | 8724 | 0.050 |
Why?
|
Coronary Care Units | 1 | 2024 | 235 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2011 | 1812 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13463 | 0.050 |
Why?
|
Kinetics | 3 | 2022 | 6273 | 0.050 |
Why?
|
Hemoglobin, Sickle | 1 | 2003 | 113 | 0.050 |
Why?
|
Hypoglycemic Agents | 3 | 2017 | 3106 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 1998 | 4780 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1994 | 1056 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2022 | 60 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 26282 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2007 | 993 | 0.050 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2007 | 396 | 0.050 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2002 | 43 | 0.050 |
Why?
|
Blood Protein Electrophoresis | 2 | 1992 | 65 | 0.050 |
Why?
|
RNA, Viral | 1 | 2010 | 2866 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2015 | 3615 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3640 | 0.050 |
Why?
|
Malaria | 1 | 1991 | 1246 | 0.050 |
Why?
|
Codon, Nonsense | 1 | 2003 | 288 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2015 | 15878 | 0.050 |
Why?
|
Phosphatidylserines | 1 | 2003 | 184 | 0.050 |
Why?
|
Age of Onset | 2 | 2020 | 3343 | 0.050 |
Why?
|
Genotype | 3 | 2011 | 13026 | 0.050 |
Why?
|
Sequence Deletion | 2 | 1996 | 1494 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2003 | 427 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2020 | 81537 | 0.050 |
Why?
|
Chemokines, CXC | 1 | 2003 | 417 | 0.050 |
Why?
|
Gene Expression Regulation | 5 | 2021 | 11895 | 0.050 |
Why?
|
Vascular Diseases | 1 | 1989 | 1161 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2022 | 404 | 0.040 |
Why?
|
Young Adult | 6 | 2024 | 59857 | 0.040 |
Why?
|
Survival Rate | 4 | 2018 | 12822 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1937 | 0.040 |
Why?
|
Thyroxine | 1 | 2004 | 665 | 0.040 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2021 | 191 | 0.040 |
Why?
|
Alternative Splicing | 2 | 1996 | 1103 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 705 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 268 | 0.040 |
Why?
|
Plasmacytoma | 1 | 2021 | 171 | 0.040 |
Why?
|
Peroxidase | 2 | 2016 | 609 | 0.040 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 643 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 694 | 0.040 |
Why?
|
Microsatellite Repeats | 2 | 2003 | 784 | 0.040 |
Why?
|
Thiazolidinediones | 1 | 2003 | 459 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14064 | 0.040 |
Why?
|
Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2019 | 1872 | 0.040 |
Why?
|
Bupivacaine | 1 | 2003 | 414 | 0.040 |
Why?
|
ROC Curve | 3 | 2014 | 3612 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.040 |
Why?
|
Hypertonic Solutions | 1 | 2019 | 82 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2004 | 665 | 0.040 |
Why?
|
Agglutination | 1 | 1998 | 42 | 0.040 |
Why?
|
Carbon Isotopes | 1 | 2020 | 451 | 0.040 |
Why?
|
Germ-Line Mutation | 1 | 2007 | 1885 | 0.040 |
Why?
|
Platelet Function Tests | 1 | 2021 | 276 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2019 | 9541 | 0.040 |
Why?
|
Inflammation | 3 | 2021 | 10843 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1132 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1926 | 0.040 |
Why?
|
Chromatography, Reverse-Phase | 1 | 2018 | 24 | 0.040 |
Why?
|
Isotope Labeling | 1 | 2020 | 389 | 0.040 |
Why?
|
B-Cell Maturation Antigen | 1 | 2019 | 148 | 0.040 |
Why?
|
Graft Survival | 2 | 2021 | 3904 | 0.040 |
Why?
|
Respiratory Insufficiency | 1 | 2007 | 1241 | 0.040 |
Why?
|
Gene Deletion | 2 | 2021 | 2667 | 0.040 |
Why?
|
Recurrence | 3 | 2018 | 8492 | 0.040 |
Why?
|
Penetrance | 1 | 2020 | 388 | 0.040 |
Why?
|
Kidney | 3 | 2020 | 7073 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 325 | 0.040 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 1998 | 103 | 0.040 |
Why?
|
Biomarkers, Pharmacological | 1 | 2019 | 161 | 0.040 |
Why?
|
Multigene Family | 1 | 2021 | 1081 | 0.040 |
Why?
|
Aorta | 2 | 2015 | 2040 | 0.040 |
Why?
|
Chymotrypsin | 1 | 1997 | 136 | 0.040 |
Why?
|
Calibration | 1 | 2020 | 812 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 865 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6306 | 0.040 |
Why?
|
Isoleucine | 1 | 1997 | 109 | 0.030 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1996 | 30 | 0.030 |
Why?
|
Heptanoic Acids | 2 | 2011 | 344 | 0.030 |
Why?
|
Cytokines | 3 | 2016 | 7417 | 0.030 |
Why?
|
Bicarbonates | 1 | 1998 | 293 | 0.030 |
Why?
|
Simvastatin | 1 | 2019 | 345 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2782 | 0.030 |
Why?
|
Polysomnography | 2 | 2014 | 1868 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2011 | 4641 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2007 | 3799 | 0.030 |
Why?
|
Antigens, CD | 1 | 2007 | 4023 | 0.030 |
Why?
|
Rhabdomyolysis | 1 | 2018 | 150 | 0.030 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1996 | 167 | 0.030 |
Why?
|
Germany | 1 | 2019 | 882 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 1998 | 417 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2013 | 2350 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2003 | 1004 | 0.030 |
Why?
|
Threonine | 1 | 1997 | 272 | 0.030 |
Why?
|
Genetic Markers | 2 | 2004 | 2603 | 0.030 |
Why?
|
Transplantation Tolerance | 1 | 2021 | 641 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2017 | 330 | 0.030 |
Why?
|
Telomerase | 1 | 2001 | 749 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 2016 | 2729 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2005 | 1218 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 1998 | 608 | 0.030 |
Why?
|
Microscopy, Electron | 3 | 1994 | 2543 | 0.030 |
Why?
|
Cystatin C | 1 | 2017 | 272 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4563 | 0.030 |
Why?
|
Cholesterol, VLDL | 1 | 2015 | 70 | 0.030 |
Why?
|
Life Style | 2 | 2020 | 3928 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2270 | 0.030 |
Why?
|
Osmotic Fragility | 1 | 1995 | 35 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1752 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5889 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1607 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11030 | 0.030 |
Why?
|
Thoracic Injuries | 1 | 2018 | 288 | 0.030 |
Why?
|
Chlorides | 1 | 1998 | 666 | 0.030 |
Why?
|
Apolipoprotein B-100 | 1 | 2015 | 157 | 0.030 |
Why?
|
Telomere | 1 | 2001 | 941 | 0.030 |
Why?
|
Interleukin-5 | 1 | 2015 | 268 | 0.030 |
Why?
|
Tosyl Compounds | 1 | 2015 | 115 | 0.030 |
Why?
|
Protein Structure, Secondary | 2 | 1995 | 1210 | 0.030 |
Why?
|
Jaundice, Neonatal | 1 | 1995 | 70 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1865 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1404 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2001 | 1775 | 0.030 |
Why?
|
Gadolinium | 1 | 2019 | 966 | 0.030 |
Why?
|
Oxygen | 2 | 2018 | 4246 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1009 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2626 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3796 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1724 | 0.030 |
Why?
|
Freeze Fracturing | 1 | 1994 | 67 | 0.030 |
Why?
|
Lactones | 1 | 2016 | 316 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2002 | 1243 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8882 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2001 | 1307 | 0.030 |
Why?
|
Body Mass Index | 3 | 2024 | 13042 | 0.030 |
Why?
|
Apolipoproteins B | 1 | 2015 | 385 | 0.030 |
Why?
|
Obesity | 3 | 2024 | 13082 | 0.030 |
Why?
|
Solubility | 2 | 2007 | 1077 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2022 | 2444 | 0.030 |
Why?
|
Leuprolide | 1 | 2015 | 310 | 0.030 |
Why?
|
Brachial Artery | 1 | 2015 | 374 | 0.030 |
Why?
|
COS Cells | 1 | 2015 | 1135 | 0.030 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 1993 | 71 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2002 | 1063 | 0.030 |
Why?
|
Galectins | 1 | 2016 | 293 | 0.030 |
Why?
|
Child | 6 | 2024 | 80568 | 0.030 |
Why?
|
Tunica Intima | 1 | 2015 | 455 | 0.030 |
Why?
|
Sodium Channel Blockers | 1 | 2014 | 170 | 0.030 |
Why?
|
Incidence | 3 | 2019 | 21513 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2010 | 0.030 |
Why?
|
Pyrroles | 2 | 2011 | 1119 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1994 | 780 | 0.030 |
Why?
|
Forensic Toxicology | 1 | 2012 | 5 | 0.030 |
Why?
|
Urine | 1 | 2014 | 363 | 0.030 |
Why?
|
Genetic Linkage | 1 | 1998 | 2342 | 0.030 |
Why?
|
Transcription Factors | 2 | 2010 | 12129 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2019 | 2627 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11090 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2020 | 838 | 0.020 |
Why?
|
Prevalence | 2 | 2021 | 15828 | 0.020 |
Why?
|
Hematocrit | 1 | 1994 | 622 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 786 | 0.020 |
Why?
|
Adolescent | 6 | 2024 | 88811 | 0.020 |
Why?
|
Anilides | 1 | 2015 | 413 | 0.020 |
Why?
|
Models, Statistical | 1 | 2006 | 5088 | 0.020 |
Why?
|
RNA Splicing | 1 | 1996 | 902 | 0.020 |
Why?
|
Child, Preschool | 4 | 2024 | 42510 | 0.020 |
Why?
|
Bilirubin | 1 | 1994 | 439 | 0.020 |
Why?
|
Gene Library | 1 | 1994 | 1066 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2017 | 912 | 0.020 |
Why?
|
Protein Binding | 2 | 2015 | 9296 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2018 | 1109 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7423 | 0.020 |
Why?
|
Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.020 |
Why?
|
Creatinine | 1 | 2017 | 1916 | 0.020 |
Why?
|
Dyspnea | 1 | 2019 | 1351 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 956 | 0.020 |
Why?
|
Eosinophilia | 1 | 2015 | 553 | 0.020 |
Why?
|
Hemin | 1 | 1990 | 51 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1937 | 0.020 |
Why?
|
Cause of Death | 2 | 2012 | 3715 | 0.020 |
Why?
|
Alanine | 1 | 1993 | 613 | 0.020 |
Why?
|
Age Factors | 2 | 2018 | 18382 | 0.020 |
Why?
|
Th1 Cells | 1 | 2016 | 1040 | 0.020 |
Why?
|
Pregnancy | 4 | 2012 | 30230 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2016 | 1555 | 0.020 |
Why?
|
Epitopes | 1 | 1997 | 2523 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1995 | 2743 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2530 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2018 | 14745 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2011 | 249 | 0.020 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2019 | 1076 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3769 | 0.020 |
Why?
|
Th2 Cells | 1 | 2016 | 1074 | 0.020 |
Why?
|
Prenylation | 1 | 2010 | 36 | 0.020 |
Why?
|
Acyl Coenzyme A | 1 | 2010 | 56 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2970 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9656 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 1998 | 1889 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
Monitoring, Ambulatory | 1 | 2013 | 357 | 0.020 |
Why?
|
Glycine | 1 | 1993 | 671 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2206 | 0.020 |
Why?
|
Phagocytosis | 1 | 2016 | 1517 | 0.020 |
Why?
|
Cardiac Myosins | 1 | 2010 | 128 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3801 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 981 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 1093 | 0.020 |
Why?
|
Abortion, Spontaneous | 1 | 1994 | 536 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1459 | 0.020 |
Why?
|
Bone Marrow | 1 | 2019 | 2916 | 0.020 |
Why?
|
Angina, Unstable | 1 | 2013 | 893 | 0.020 |
Why?
|
Glutamic Acid | 1 | 1995 | 1181 | 0.020 |
Why?
|
Protein Conformation | 1 | 1996 | 3945 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12973 | 0.020 |
Why?
|
Biological Evolution | 1 | 1994 | 1075 | 0.020 |
Why?
|
Myosin Heavy Chains | 1 | 2010 | 403 | 0.020 |
Why?
|
Hematinics | 1 | 2011 | 282 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3430 | 0.020 |
Why?
|
Assisted Circulation | 1 | 2008 | 99 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 848 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2003 | 3444 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2018 | 1919 | 0.020 |
Why?
|
Automation | 1 | 2011 | 585 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6491 | 0.020 |
Why?
|
Rest | 1 | 2013 | 940 | 0.020 |
Why?
|
Molecular Structure | 1 | 1992 | 1880 | 0.020 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 1989 | 132 | 0.020 |
Why?
|
Triglycerides | 1 | 2015 | 2440 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
Apoptosis | 2 | 2016 | 9505 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 1995 | 1424 | 0.020 |
Why?
|
Syndrome | 2 | 2006 | 3271 | 0.020 |
Why?
|
Research Design | 2 | 2017 | 6204 | 0.020 |
Why?
|
Immunoblotting | 1 | 1990 | 1643 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2048 | 0.020 |
Why?
|
Chromosome Breakage | 1 | 2007 | 159 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6838 | 0.020 |
Why?
|
Death | 1 | 2011 | 686 | 0.020 |
Why?
|
Erythropoietin | 1 | 2011 | 716 | 0.020 |
Why?
|
United States | 3 | 2019 | 72909 | 0.020 |
Why?
|
Signal Transduction | 3 | 2016 | 23597 | 0.020 |
Why?
|
DNA Damage | 1 | 2016 | 2462 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1994 | 4617 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5330 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1990 | 500 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2015 | 2430 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36426 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2007 | 210 | 0.020 |
Why?
|
Fucosyltransferases | 1 | 2006 | 118 | 0.020 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 240 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36547 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2008 | 539 | 0.020 |
Why?
|
Internationality | 1 | 2011 | 1007 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3238 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2010 | 855 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8603 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1990 | 2219 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9334 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6321 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2011 | 1404 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2596 | 0.010 |
Why?
|
Retroviridae | 1 | 2006 | 845 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4213 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1989 | 3049 | 0.010 |
Why?
|
Logistic Models | 2 | 2010 | 13273 | 0.010 |
Why?
|
Adiposity | 1 | 2014 | 1891 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1325 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2012 | 6202 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2006 | 827 | 0.010 |
Why?
|
Genome, Human | 1 | 1996 | 4443 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5986 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1994 | 5784 | 0.010 |
Why?
|
Actins | 1 | 1990 | 2057 | 0.010 |
Why?
|
Fibrosis | 1 | 2010 | 2073 | 0.010 |
Why?
|
Ventricular Function, Right | 1 | 2007 | 629 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 2007 | 534 | 0.010 |
Why?
|
Stereoisomerism | 1 | 2003 | 612 | 0.010 |
Why?
|
Pediatrics | 1 | 2017 | 3609 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 457 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2616 | 0.010 |
Why?
|
Receptors, Endothelin | 1 | 2002 | 56 | 0.010 |
Why?
|
Quality Control | 1 | 2005 | 835 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2014 | 3314 | 0.010 |
Why?
|
Receptor, Endothelin B | 1 | 2002 | 46 | 0.010 |
Why?
|
Postoperative Care | 1 | 2008 | 1475 | 0.010 |
Why?
|
Spain | 1 | 2003 | 483 | 0.010 |
Why?
|
Platelet Activating Factor | 1 | 2002 | 142 | 0.010 |
Why?
|
Rubidium Radioisotopes | 1 | 2002 | 101 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 2002 | 157 | 0.010 |
Why?
|
Data Collection | 1 | 2011 | 3318 | 0.010 |
Why?
|
Probability | 1 | 2006 | 2474 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7599 | 0.010 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2002 | 282 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5873 | 0.010 |
Why?
|
Thyrotropin | 1 | 2004 | 834 | 0.010 |
Why?
|
Software | 1 | 1995 | 4462 | 0.010 |
Why?
|
Ventricular Fibrillation | 1 | 2003 | 538 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11639 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2011 | 3690 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4863 | 0.010 |
Why?
|
Cell Size | 1 | 2002 | 626 | 0.010 |
Why?
|
Receptors, CCR5 | 1 | 2002 | 491 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3447 | 0.010 |
Why?
|
Ligands | 1 | 2006 | 3272 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2014 | 2177 | 0.010 |
Why?
|
Cell Communication | 1 | 2006 | 1660 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2001 | 698 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1055 | 0.010 |
Why?
|
Neoplasms | 1 | 2007 | 22340 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 852 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2227 | 0.010 |
Why?
|
Homozygote | 2 | 1994 | 1774 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2007 | 2395 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1469 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3586 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2002 | 1202 | 0.010 |
Why?
|
Estradiol | 1 | 2004 | 1947 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3690 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2004 | 4851 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2002 | 1181 | 0.010 |
Why?
|
Oligopeptides | 1 | 2002 | 1193 | 0.010 |
Why?
|
RNA, Complementary | 1 | 1995 | 46 | 0.010 |
Why?
|
Microsomes | 1 | 1995 | 252 | 0.010 |
Why?
|
Biopolymers | 1 | 1995 | 181 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 1995 | 386 | 0.010 |
Why?
|
Length of Stay | 1 | 2008 | 6486 | 0.010 |
Why?
|
Xenopus | 1 | 1995 | 709 | 0.010 |
Why?
|
Hospitals | 1 | 2007 | 3886 | 0.010 |
Why?
|
Heart | 1 | 2006 | 4419 | 0.010 |
Why?
|
Heart Arrest | 1 | 2003 | 1516 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 1995 | 662 | 0.010 |
Why?
|
Skin | 1 | 2006 | 4481 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8107 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1993 | 1430 | 0.010 |
Why?
|
Biological Transport | 1 | 1995 | 2081 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1993 | 462 | 0.010 |
Why?
|
Fibroblasts | 1 | 2001 | 4161 | 0.010 |
Why?
|
Oocytes | 1 | 1995 | 1168 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 3594 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5769 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1995 | 2089 | 0.000 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6958 | 0.000 |
Why?
|
Rats | 1 | 2003 | 23708 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9600 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2007 | 21069 | 0.000 |
Why?
|